Spanish Red Biotech Pipeline

MSD

MK4830

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: MK-4830 as Monotherapy and in Combination with Pembrolizumab for Participants with Advanced Solid tumors
Phase: 1Phase I in Spain